8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-24-011681
Material agreement · Unregistered share sale · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d699582d8k.htm…